plx73086
Tenosynovial Giant Cell Tumor
PlexxikonPhase 1Dormant
CC
43/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 28/ 100
- Competitive Position
- 95/ 100
Competitive context
1 Active assets in the Tenosynovial Giant Cell Tumor cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Absk021 Abbisko Therapeutics Co, Ltd | Phase 1 | CC |
plx7486 tsoh Plexxikon | Phase 1 | CC |
Same molecule, other indications
plx73086 is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →